DE2926472A1 - Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel - Google Patents

Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel

Info

Publication number
DE2926472A1
DE2926472A1 DE19792926472 DE2926472A DE2926472A1 DE 2926472 A1 DE2926472 A1 DE 2926472A1 DE 19792926472 DE19792926472 DE 19792926472 DE 2926472 A DE2926472 A DE 2926472A DE 2926472 A1 DE2926472 A1 DE 2926472A1
Authority
DE
Germany
Prior art keywords
methyl
amino
deep
ethyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19792926472
Other languages
German (de)
English (en)
Inventor
Guenther Dr Engelhardt
Johannes Dipl Chem Dr Keck
Gerd Dipl Chem Dr Krueger
Klaus Dipl Chem Dr Noll
Helmut Dipl Chem Dr Pieper
Norbert Dr Promberger
Rainer Dipl Chem Dr Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Priority to DE19792926472 priority Critical patent/DE2926472A1/de
Priority to GR62113A priority patent/GR68757B/el
Priority to AT80103099T priority patent/ATE3415T1/de
Priority to EP80103099A priority patent/EP0024282B1/de
Priority to DE8080103099T priority patent/DE3063290D1/de
Priority to JP7828180A priority patent/JPS5610155A/ja
Priority to US06/158,587 priority patent/US4362738A/en
Priority to PT71453A priority patent/PT71453B/pt
Priority to ES492845A priority patent/ES8201128A1/es
Priority to NO801931A priority patent/NO801931L/no
Priority to FI802049A priority patent/FI802049A7/fi
Priority to NZ194172A priority patent/NZ194172A/xx
Priority to IL60418A priority patent/IL60418A/xx
Priority to AU59735/80A priority patent/AU538776B2/en
Priority to DK279480A priority patent/DK279480A/da
Priority to ZA00803907A priority patent/ZA803907B/xx
Priority to CA000355151A priority patent/CA1140564A/en
Priority to PH24211A priority patent/PH16813A/en
Publication of DE2926472A1 publication Critical patent/DE2926472A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19792926472 1979-06-30 1979-06-30 Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel Withdrawn DE2926472A1 (de)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DE19792926472 DE2926472A1 (de) 1979-06-30 1979-06-30 Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel
GR62113A GR68757B (enExample) 1979-06-30 1980-06-03
AT80103099T ATE3415T1 (de) 1979-06-30 1980-06-04 Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel.
EP80103099A EP0024282B1 (de) 1979-06-30 1980-06-04 Neue Benzoylderivate, deren Herstellung und deren Verwendung als Arzneimittel
DE8080103099T DE3063290D1 (en) 1979-06-30 1980-06-04 Benzoyl derivatives, their preparation and their use as medicines
JP7828180A JPS5610155A (en) 1979-06-30 1980-06-10 Novel benzoyl derivative
US06/158,587 US4362738A (en) 1979-06-30 1980-06-11 Esters and amides containing the 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetyl moiety
PT71453A PT71453B (de) 1979-06-30 1980-06-25 Neue benzoylderivate deren herstellung und deren verwendung als arzneimittel
ES492845A ES8201128A1 (es) 1979-06-30 1980-06-27 Procedimiento para la preparacion de nuevos derivados ben- zoilicos
NO801931A NO801931L (no) 1979-06-30 1980-06-27 Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoylderivater
FI802049A FI802049A7 (fi) 1979-06-30 1980-06-27 Uusia bentsoyylijohdoksia, niiden valmistaminen ja niiden käyttö lääkeaineina.
NZ194172A NZ194172A (en) 1979-06-30 1980-06-27 Benzoyl derivatives preparation and antiinflammatory compositions
IL60418A IL60418A (en) 1979-06-30 1980-06-27 Benzoyl derivatives,their preparation and pharmaceutical compositions containing them
AU59735/80A AU538776B2 (en) 1979-06-30 1980-06-27 Chemical compounds
DK279480A DK279480A (da) 1979-06-30 1980-06-27 Fremgangsmaade til fremstilling af benzoylderivater
ZA00803907A ZA803907B (en) 1979-06-30 1980-06-30 Benzoyl derivatives,processes for their preparation,pharmaceutical compositions containing these,and use thereof
CA000355151A CA1140564A (en) 1979-06-30 1980-06-30 Benzoyl derivatives, their preparation and their use as pharmaceutical compositions
PH24211A PH16813A (en) 1979-06-30 1980-06-30 Esters and amides containing the 1-(4-chloro-benzoyl)-5-methoxy-2-methyl-1h-indole-3-acetyl moiety

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792926472 DE2926472A1 (de) 1979-06-30 1979-06-30 Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DE2926472A1 true DE2926472A1 (de) 1981-01-15

Family

ID=6074591

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19792926472 Withdrawn DE2926472A1 (de) 1979-06-30 1979-06-30 Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel
DE8080103099T Expired DE3063290D1 (en) 1979-06-30 1980-06-04 Benzoyl derivatives, their preparation and their use as medicines

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8080103099T Expired DE3063290D1 (en) 1979-06-30 1980-06-04 Benzoyl derivatives, their preparation and their use as medicines

Country Status (17)

Country Link
US (1) US4362738A (enExample)
EP (1) EP0024282B1 (enExample)
JP (1) JPS5610155A (enExample)
AT (1) ATE3415T1 (enExample)
AU (1) AU538776B2 (enExample)
CA (1) CA1140564A (enExample)
DE (2) DE2926472A1 (enExample)
DK (1) DK279480A (enExample)
ES (1) ES8201128A1 (enExample)
FI (1) FI802049A7 (enExample)
GR (1) GR68757B (enExample)
IL (1) IL60418A (enExample)
NO (1) NO801931L (enExample)
NZ (1) NZ194172A (enExample)
PH (1) PH16813A (enExample)
PT (1) PT71453B (enExample)
ZA (1) ZA803907B (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
USRE41151E1 (en) 2000-06-23 2010-02-23 Medinox, Inc. Protected forms of pharmacologically active agents and uses thereof
US7736624B2 (en) 2006-06-19 2010-06-15 Univ Vanderbilt Methods and compositions for diagnostic and therapeutic targeting of COX-2
US8168656B2 (en) 2004-04-26 2012-05-01 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57194563U (enExample) * 1982-04-13 1982-12-09
US4748184A (en) * 1982-07-26 1988-05-31 E. I. Du Pont De Nemours And Company Aryl substituted aminomethyl benzene derivatives having antiarrhythmic utility
US4562201A (en) * 1982-07-26 1985-12-31 American Hospital Supply Corporation Aminomethyl benzanilides
US4755527A (en) * 1982-07-26 1988-07-05 E. I. Du Pont De Nemours And Company Aryl substituted aminomethyl benzene derivatives
JPS6011483A (ja) * 1983-06-29 1985-01-21 Taiho Yakuhin Kogyo Kk ピペラジン化合物
GB8410899D0 (en) * 1984-04-27 1984-06-06 Ici Plc Phenol derivatives
ES8605220A1 (es) * 1985-10-25 1986-03-16 Espanola Prod Quimicos Procedimiento de preparacion de esteres del dietilenglicol
US5569659A (en) * 1991-09-11 1996-10-29 Mcneilab, Inc. 4-arylpiperazines and 4-arylpiperidines
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
BR9510360A (pt) * 1994-12-23 1997-12-23 Thomae Gmbh Dr K Derivados de piperazina medicamentos contendo esses compostos sua aplicação e processo para sua preparação
DE69632338T2 (de) * 1995-03-07 2005-05-12 Santen Pharmaceutical Co., Ltd Neue aminosäurederivate, die eine n, n-dialkylaminophenylgruppe haben

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3564009A (en) * 1966-01-13 1971-02-16 Sumitomo Chemical Co Process for producing 1-acylindole derivatives
AT332375B (de) * 1973-04-13 1976-09-27 Thomae Gmbh Dr K Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
IT1043937B (it) * 1974-08-12 1980-02-29 Rotta Research Lab Defivati della n benzoil n' n' di ,n, propil, dl, isoglutamina ad attivita antiartrosioa ed antiin fiammatoria

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6399647B2 (en) 1999-01-07 2002-06-04 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
USRE41151E1 (en) 2000-06-23 2010-02-23 Medinox, Inc. Protected forms of pharmacologically active agents and uses thereof
US8168656B2 (en) 2004-04-26 2012-05-01 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
US7736624B2 (en) 2006-06-19 2010-06-15 Univ Vanderbilt Methods and compositions for diagnostic and therapeutic targeting of COX-2

Also Published As

Publication number Publication date
FI802049A7 (fi) 1981-01-01
ES492845A0 (es) 1981-11-01
JPS5610155A (en) 1981-02-02
ATE3415T1 (de) 1983-06-15
EP0024282A1 (de) 1981-03-04
GR68757B (enExample) 1982-02-17
PT71453A (de) 1980-07-01
ES8201128A1 (es) 1981-11-01
PT71453B (de) 1981-10-23
IL60418A0 (en) 1980-09-16
EP0024282B1 (de) 1983-05-18
AU5973580A (en) 1981-02-05
PH16813A (en) 1984-03-06
DK279480A (da) 1980-12-31
NZ194172A (en) 1982-08-17
NO801931L (no) 1981-01-02
IL60418A (en) 1984-02-29
DE3063290D1 (en) 1983-07-07
CA1140564A (en) 1983-02-01
AU538776B2 (en) 1984-08-30
US4362738A (en) 1982-12-07
ZA803907B (en) 1982-02-24

Similar Documents

Publication Publication Date Title
DE3855501T2 (de) Chinolin-derivate als antagonisten von leukotrien d 4?
DE69531458T2 (de) Chinolinderivate als tachykinin nk3 rezeptor antagonisten
DE3880396T2 (de) Zur Behandlung von neurodegenerativen Erkrankungen verwendbare Kynurensäurederivate.
DE69714265T2 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE19546918A1 (de) Bicyclische Heterocyclen
EP0049355A1 (de) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridin oder chinolin)-3-carbonsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US4362738A (en) Esters and amides containing the 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetyl moiety
DE69622731T2 (de) Tetrahydrochinoline als nmda antagonisten
DD235256A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinone
EP0089028B1 (de) Neue Theophyllin-Derivate und Verfahren zu ihrer Herstellung
DE3216843C2 (de) 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0008645A1 (de) Alkoxyphenylpyrrolidone, Verfahren zu ihrer Herstellung und Arzneimittel auf Basis dieser Verbindungen
EP0298921B1 (de) 1,2-Benzisoxazole und 1,2-Benzisothiazole
DD282457A5 (de) Verfahren zur herstellung neuer heterocyclischer derivate
DE3781703T2 (de) 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE2128375B2 (de) Basische substituierte Alkylidenamino-oxyalkyl-carbonsäureester, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0124630B1 (de) Pyrimidin-Thioalkylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindung enthaltende Arzneimittel
DE19615263A1 (de) Benzyloxy-substituierte Phenylglycinolamide
DE69006675T2 (de) Aroylharnstoffe.
DD139578A5 (de) Verfahren zur herstellung neuer benzopyranderivate
EP0072961A1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0266308A1 (de) Indolo-pyrazino-benzodiazepin-Derivate
DE2605824C3 (de) N-Acylaniline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0165897B1 (de) Neue Resorcinäther
DE69509510T2 (de) 2-(aminoalkoxy) phenylalkylamine mit entzündungskennenden eigenschaften

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee